Funding Rounds
Be Biopharma Series B round, April 2022
Be BiopharmaBe Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.
Summary
Stage: Series B
Raised Amount: $130.00M
Raised Date: 2022-04-16
